Were Analysts Bullish CNO Financial Group, Inc. (NYSE:CNO) This Week?

July 14, 2018 - By Hannah Black

CNO Financial Group, Inc. (NYSE:CNO) Logo

CNO Financial Group, Inc. (NYSE:CNO) Ratings Coverage

Among 3 analysts covering CNO Financial (NYSE:CNO), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. CNO Financial has $27.0 highest and $25 lowest target. $25’s average target is 27.68% above currents $19.58 stock price. CNO Financial had 4 analyst reports since February 13, 2018 according to SRatingsIntel. The firm has “Buy” rating given on Monday, March 12 by William Blair. The firm has “Equal-Weight” rating by Morgan Stanley given on Thursday, May 17. FBR Capital maintained the shares of CNO in report on Tuesday, June 12 with “Buy” rating. Below is a list of CNO Financial Group, Inc. (NYSE:CNO) latest ratings and price target changes.

12/06/2018 Broker: FBR Capital Old Rating: Buy New Rating: Buy Old Target: $27 New Target: $25 Maintain
17/05/2018 Broker: Morgan Stanley Old Rating: Underweight New Rating: Equal-Weight Upgrade
12/03/2018 Broker: William Blair Rating: Buy Initiate
13/02/2018 Broker: FBR Capital Rating: Buy New Target: $27.0

The stock increased 1.19% or $0.23 during the last trading session, reaching $19.58. About 1.01 million shares traded. CNO Financial Group, Inc. (NYSE:CNO) has risen 0.29% since July 14, 2017 and is uptrending. It has underperformed by 12.28% the S&P500.

CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. The company has market cap of $3.28 billion. It operates through Bankers Life, Washington National, Colonial Penn, and Long-Term Care in Run Off divisions. It has a 16.94 P/E ratio. The Bankers Life segment markets and distributes Medicare supplement insurance, interest-sensitive and traditional life insurance, fixed annuities, and long-term care insurance products; and Medicare advantage and prescription drug plan products through various distribution and marketing agreements.

Another recent and important CNO Financial Group, Inc. (NYSE:CNO) news was published by Prnewswire.com which published an article titled: “CNO Financial Names Dana Allen Vice President of Product Marketing” on June 25, 2018.

CNO Financial Group, Inc. (NYSE:CNO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: